-
Establishment and duration of protective immunity against SARS-CoV-2 in...
Establishment and duration of protective immunity against SARS-CoV-2 in relation to severity of SARS-CoV-2 infection.; Establishment and duration of protective immunity against... -
Samenwerken tegen Corona met Intensive Care Data
Samenwerken tegen Corona met Intensive Care Data -
TURN-COVID: The Dutch neutralizing monoclonal antibody cohort against...
TURN-COVID - The Dutch Cohort Study for the Evaluation of the Use of Neutralizing Monoclonal Antibodies and Other Antiviral Agents Against SARS-CoV-2 -
Caging the dragon: translational approach to unravel and prevent COVID-19...
Caging the dragon: translational approach to unravel and prevent COVID-19 associated thrombosis (10430012010004) -
Inzicht in aanhoudende klachten na Covid-19 besmetting: een mixed methods benadering
Inzicht in aanhoudende klachten na Covid-19 besmetting: een mixed methods benadering -
ANAkinra voor de behandeling van CORonavirus infectious disease 2019 op de...
ANAkinra voor de behandeling van CORonavirus infectious disease 2019 op de Intensive Care (ANACOR-IC) -
Monitoring the evolution spread and transmission of SARS-CoV-2 through whole...
Monitoring the evolution spread and transmission of SARS-CoV-2 through whole genome sequencing to enable fast genotype to phenotype prediction -
A Phase I-II study of virus neutralizing antibodies against SARS-CoV-2. A...
A Phase I-II study of virus neutralizing antibodies against SARS-CoV-2. A focus on convalescent plasma and hyperimmune anti-SARS-CoV-2 immunoglobulines -
COVID-19 Follow-up care paths and Long-term Outcomes Within the Dutch health...
COVID-19 Follow-up care paths and Long-term Outcomes Within the Dutch health care system: a combined rehabilitation, pulmonary, and intensive care perspective -
CounterCOVID study - oral imatinib for COVID-19
CounterCOVID study - oral imatinib for COVID-19 -
Preclinical development of an antiviral small molecule drug against COVID-19
Preclinical development of an antiviral small molecule drug against COVID-19 -
Understanding the two faces of the COVID-19 immune response to predict...
Understanding the two faces of the COVID-19 immune response to predict clinical course and define strategies for early and late phase intervention -
Frequency of opportunistic pathogens in Covid-19 and their impact on clinical outcome
Frequency of opportunistic pathogens in Covid-19 and their impact on clinical outcome -
COVID-NL cohort LUMC
Clinical data of LUMC COVID-NL cohort -
TRACE-II: outcome in patients undergoing postponed elective surgery during...
TRACE-II: outcome in patients undergoing postponed elective surgery during the COVID-19 pandemic.
U kunt ook het register raadplegen met behulp van de API (see API documentatie).